Dr. Jay Luly | President and Chief Executive Officer |
Jennifer Viera | Investor Relations |
Paul Mellett | CFO |
Nathalie Adda | Chief Medical Officer |
Brian Abrahams | RBC Capital Markets |
Akash Tewari | Jefferies |
Unidentified Analyst 1 | Piper Sandler |
Brian Skorney | Baird |
Roy Buchanan | JMP Securities |
Eric Joseph | JP Morgan |
Zegbeh Jallah | Roth Capital Partners |
Unidentified Analyst 2 | Analyst |
Lisa Vago | Evercore |
Good afternoon. And welcome to Enanta Pharmaceuticals Fiscal Fourth Quarter and year-end 2021 financial results conference call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded.